Phio Pharmaceuticals Corp. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
King Of Prussia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Phio Pharmaceuticals Corp. has filed 870 SEC EDGAR filings since 25 Oct 2011

SEC filing history

Showing 101-125 of 870 matching filings.

Per page
25
Current page
5
8-K File 001-36304

CURRENT REPORT

Filing date
14 Jan 2025
Reporting date
13 Jan 2025
Next action
Verify source filing
424B5 File 333-279557

PROSPECTUS

Filing date
14 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
13 Jan 2025
Reporting date
13 Jan 2025
Next action
Verify source filing
D File 021-534479

D filing

Filing date
07 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-534199

D filing

Filing date
03 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-86901

SCHEDULE 13G filing

Filing date
27 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-86901

SCHEDULE 13G filing

Filing date
26 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279557

FORM 424B5

Filing date
23 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
20 Dec 2024
Reporting date
19 Dec 2024
Next action
Verify source filing
424B5 File 333-279557

PROSPECTUS SUPPLEMENT

Filing date
20 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36304

FORM 10-Q FOR SEPT 2024

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13G/A File 005-86901

AMENDMENT NO. 5 TO SCHEDULE 13G

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Aug 2024
Reporting date
13 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

CURRENT REPORT

Filing date
14 Aug 2024
Reporting date
14 Aug 2024
Next action
Verify source filing
10-Q File 001-36304

FORM 10-Q FOR JUNE 2024

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .